• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Cord Blood Licensure: A Workshop

The Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER) and AABB are collaborating to develop a workshop entitled: Cord Blood Licensure: A Workshop

The purpose of the workshop is to provide an educational opportunity for potential stakeholders such as cord blood banks, registries, individual physicians, and other stakeholders to learn about the pathway to licensure or IND submission for minimally manipulated allogeneic unrelated cord blood for specified indications.

Date and Time:  The workshop will be held on March 8, 2010 8:30 a.m. to 5:00 p.m., and March 9, 2010 from 8.30 am to 5:00 p.m.

Location:  The workshop will be held at the Hilton Washington D.C./Rockville, Hotel and Executive Meeting Center. 1750 Rockville Pike, Rockville, MD 20852

Contact Person: Bernadette Kawaley, Center for Biologics Evaluation and Research (HFM-43), Food and Drug Administration, 1401 Rockville Pike, Suite 200N, Rockville, MD 20852-1448, (301) 827-2000, Fax (301) 827-3079; email: CBERTraining@fda.hhs.gov  (Subject line: Cord Blood Workshop).

Registration: Meeting information and registration

Special Accommodations:  If you need special accommodations due to a disability, please contact Bernadette Kawaley (see Contact Person) at least 7 days in advance.